Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

Best Haematologists in Glasgow, UK

0 results found for Haematologists in Glasgow, UK

Sort by:
We didn't find any results for your search within 15 miles of Glasgow, UK
Here are closest specialists matching your search
Preston New Road, Blackburn, United Kingdom, BB2 7AE - 161.28 miles
BMI The Beardwood Hospital - 161.28 miles
Preston New Road, Blackburn, United Kingdom, BB2 7AE
16 years of experience
Acute Myeloid Leukaemia (AML), Blood Cancer, Bone Marrow Tests & Biopsies, Chronic Lymphocytic Leukaemia + 4 more

Dr Jagdish Adiyodi is a Consultant Haematologist with over two decades of experience in the treatment and management of blood conditions, such as myeloma, lymphoma and leukaemia. He sees private patients at the BMI Beardwod Hospital.

Dr Adiyodi qualified and trained in internal Medicine at Manipal University, allowing him to achieve his MD. This also gave him the opportunity to gain a wide base of Internal Medicine and Critical care knowledge, before coming to the UK in 2004, where he underwent further training in haemato-oncology at the The Royal Liverpool University Hospital. Upon completion of training, he was appointed Consultant Haematologist at the Royal Blackburn Hospital.

Read more
Video consultation
NEW!
Dr Salim Shafeek - Haematologists
Priory Rd,, Edgbaston, United Kingdom, B5 7UG - 253.55 miles
BMI The Priory Hospital - 253.55 miles
Priory Rd,, Edgbaston, United Kingdom, B5 7UG
23 years of experience
Chronic Lymphocytic Leukaemia, Acute Myeloid Leukaemia (AML), Anaemia

 

 

Dr Salim Shafeek is a consultant Haematologist practising at Worcestershire Royal NHS Hospital, where he is Clinical Director for Haematology & Oncology, and Head of Clinical Haematology for the Worcestershire County. At present he is actively involved in the reorganisation of the cancer network for the county. Dr Shafeek has particular clinical interests in lymphoma and myeloma. In his clinic, he treats general haematology disease, including acute and chronic leukaemia, haemato-oncology, red cell disorders and thrombosis haemostasis. He underwent training in haemato-oncology at the Queen Elizabeth Hospital, at Birmingham Heartlands Hospital, and at the University Hospitals Coventry and Warwick. At present, he is a PACES examiner for the MRCP (UK) exam at the Royal College of Physicians of London, Edinburgh & Glasgow. He enjoys teaching both undergraduate and postgraduate students at the University of Birmingham, where he has been a Senior Lecturer in Haematology since 2005. This role gives him close links to ongoing cancer studies and academic research activities into Leukaemia, Myeloma, Lymphoma, and Myeloproliferative disorder.  He works closely with the Cure Leukemia Charity and is actively involved in fundraising activities for this charity, and for the Breast Cancer unit in Worcester. Away from the clinic, Dr Shafeek enjoys photography and cricket and is married with two children.


Diseases, Medical Tests and Treatments

  • Blood transfusion
  • Venesection
  • Bone Marrow & Trephine biopsy
  • Chemotherapy
  • Blood disorder testing
  • Haemtological oncology
  • Lymphoma
  • Myeloma
Read more
Gartree Road, Oadby, Leicester, United Kingdom, LE2 2FF - 258.14 miles
Spire Leicester Hospital - 258.14 miles
Gartree Road, Oadby, Leicester, United Kingdom, LE2 2FF
24 years of experience
Amyloidosis, Anaemia, Bone Marrow Tests & Biopsies, Chronic Lymphocytic Leukaemia + 4 more

Dr Mamta Garg has been a consultant Haematologist since 2002 and has been working at Leicester Royal Infirmary since 2005. She has a special interest in Plasma cells (Multiple Myeloma MGUS and Amyloidosis) and Myeloproliferative Neoplasms (Polycythaemia Vera, Essential Thrombocythaemia and Myelofibrosis). She is specifically interested in making early diagnoses of myeloma and has made changes in clinical practice and writes regularly to GPs via a newsletter.  

Dr Garg undertook her undergraduate and postgraduate medical training at BJ Medical College Pune India, obtaining her MD in medicine from the University of Poona. Following this, she worked as a postgraduate at PGIMER Chandigarh before migrating to the UK. She then undertook her specialist training in Haematology in Manchester working towards an MD in Molecular Haematology at Manchester Royal Infirmary under the guidance of Prof JAL Yin. During this time she worked on minimal residual disease in acute myeloid leukaemia using the WT1 gene as a marker.

Dr Garg is a Chair of the British Society of Haematology Taskforce for Guidelines in General Haematology and sits in the MPN subgroup of the NCRI Haemato-Oncology Clinical Research Group. She has been part of many advisory boards of pharmaceutical companies specialising in myeloma and MPN. She is a member of the British and European Society of Haematology and International Myeloma Working Group (IMWG) 

She is Subspecialty Lead for NCRI East Midlands for Malignant Haematology in division 1 and non-malignant haematology in Division 3 and is committed to a healthy trial portfolio in national and international clinical trials across East Midlands. 

Her own Clinical trials portfolio at Leicester is as follows: Dr Garg has been Chief Investigator for 3 international clinical trials in myeloma. She has been Principal investigator for 31 trials and sub-investigator in 5 trials in the last 5 years, many of which have led to oral and poster presentations in international meetings and publications in high impact journals. This has given Leicester the Myeloma Team a well-deserved national and international recognition. She is on the panel for Trial management groups, Guidelines writing committee, advisory boards for pharmaceutical companies and scope consultations for NICE and has been awarded Associate Professorship by the University of Leicester. 

By taking part in clinical trials, patients have availed to new drugs years before they are available on NHSE/CDF that has led to significantly increased overall survival and quality of life. Moreover, trial activity has directly saved in our usage on NICE and Cancer drug fund approved drugs. Figures periodically presented to the CCG and have allowed increasing our clinical nurse and pharmacy support in the trials unit. 

Her real interest lies in real-world data collection and publication for peer review and annual reports and understanding diseases and outcomes. 

· She has recently published data on my ITP cohort on whom I have been collecting data prospectively for the last 10 years. 

· She has worked on the use of Pegylated interferon (Pegasys) in MPNs and has presented data in a national and international meeting on its use in a single centre and am collecting UK wide data via NCRI MPN subgroup committee. We plan to make a case for making Pegasys available to all trusts as well as to Roche as the plan is to stop manufacturing it by 2026. 

· She plans to take part in an international audit project again on real-world data in Myeloma called HONEUR project and we are in the midst of implementing it. To get help with the data collection, analysing results and publication – I am working with a medical student in her LINK project. 

· Her original data collection on Urine PCR and ACR has now been incorporated into the algorithm in suspecting myeloma.

· She is passionate about raising awareness about myeloma and early diagnosis and work closely with primary care physicians via regular GP newsletter lectures and advice and guidance.  

Read more
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS - 298.62 miles
GenesisCare Milton Keynes - 298.62 miles
Sunrise Parkway, Linford Wood, Milton Keynes, United Kingdom, MK14 6LS
19 years of experience
Acute Myeloid Leukaemia (AML), Amyloidosis, Anaemia, Blood Cancer + 9 more

Dr Moez Dungarwalla is a Haematology specialist with the current NHS base Milton Keynes NHS Trust. He also works for the private practices MBI The Saxon Clinic and Genesis Care Milton Keynes. Dr Dungarwalla specialises in Haemato-oncology and his areas of interest are Leukaemia, Lymphoma, Myeloma, Anaemia, Myeloproliferative disorders, Thrombosis, Haemochromatosis, Bleeding disorders, Thrombophilia and Myelodysplasia. 

Dr Dungarwalla qualified as a doctor from Imperial College School of Medicine in 2000. He completed specialist training in Haematology and trained internal medicine at Royal Marsden Hospital, in London. In 2003 he attained a membership an MRCP and in 2007 completed a Fellowship Examination of the Royal College of Pathologists. His many years of education and clinical expertise make him an expert in his field.

Dr Dungarwalla is active in research and has published in many peer-reviewed scientific journals regarding topics including advanced refractory chronic lymphocytic leukaemia, autoimmune neutropenia and pure red cell aplasia. He also has many memberships including Member of the European Society of Medical Oncology (ESMO).


Diseases, Medical Tests and Treatments
  • chemotherapy
  • venesection
  • intravenous iron infusion
  • blood transfusion
  • Ablation therapy
  • Biological therapy for cancer
  • Leukaemia
  • Lymphoma
  • Myeloma
  • Anaemia
  • Myeloproliferative disorders
  • Thrombosis
  • Haemochromatosis
  • Bleeding disorders
  • Thrombophilia
  • Myelodysplasia
Read more
30 New Road Impington, Cambridge, United Kingdom, CB24 9EL - 306.07 miles
Spire Cambridge Lea Hospital - 306.07 miles
30 New Road Impington, Cambridge, United Kingdom, CB24 9EL
25 years of experience
Chronic Lymphocytic Leukaemia, Hodgkin Lymphoma, Lymphoma, Non-Hodgkin Lymphoma + 17 more

Professor George Follows is a Consultant Haematologist at Cambridge University Addenbrookes Hospital where he is the clinical lead for the Lymphoma / Chronic Lymphocytic Leukaemia service. He is the Professor of Haematology at the Anglia Ruskin Medical School and a Univerity Lecturer at the University of Cambridge.

Dr Follows graduated from Oxford University  completed general medical and haematology training at a number of large UK centres including Newcastle, Leeds and Edinburgh. He completed his Phd in Leeds and his post-doctoral research in Cambridge.

He is extremely experienced in his field and has a number of regional, national and international roles including chairmanship of the UK CLL Forum and chair of the UK BCSH Hodgkin Lymphoma Guidelines Panel. In addition to this, he is the Clinical Research Lead for Haematology in the Eastern Region and Chair of the East of England Lymphoma MDT. Along with his large NHS practice, he supervises a number of clinical research trials treating Leukaemia and Lymphoma patients from his research clinic at Addenbrookes and continues to publish widely in the field of blood cancer research. He is a partner in Cambridge Haematology Limited and he undertakes private practice at GenesisCare Newmarket, Nuffield and Spire hospitals in Cambridge.

Diseases, Medical Tests and Treatments

  • Chemotherapy
  • Haemato-oncology
  • Hodgkin's disease
  • Leukaemia
  • Lymphoma
  • Chronic Lymphocytic Leukaemia CLL
  • Non Hodgkins Lymphoma
  • Anaemia
  • Haematological oncology
  • Blood transfusions
Read more
300 Park Ave, Bristol, United Kingdom, BS32 4SY - 306.20 miles
GenesisCare Bristol - 306.20 miles
300 Park Ave, Bristol, United Kingdom, BS32 4SY
18 years of experience
Acute Myeloid Leukaemia (AML), Anaemia, Blood Cancer, Bone Marrow Tests & Biopsies + 9 more

Dr. Mehta has been a Consultant Haematologist for over 10 years with experience in benign, malignant and laboratory haematology. Her expertise is in red cell disorders (anaemias) and malignancies like acute and chronic leukaemias, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

Dr. Mehta has extensive experience in laboratory haematology and providing interpretation and guidance on haematological lab investigations. She has a keen research interest in myeloid disorders and leukaemias, leading her to open several national and international clinical trials for these conditions in Bristol allowing access to novel therapies to patients in the region.

Dr. Mehta is currently the Principal Investigator for eight clinical trials in Bristol and Chief Investigator for a local research study and an international leukaemia trial. In addition to this she is currently the Clinical Lead for the department of Haematology at University Hospitals Bristol NHS Trust as well as the clinical lead on research projects relating to biosensors and chemotherapy in cancers at the University of the West of England.

Another post Dr. Mehta holds is the lead for leukaemia service at UHBristol NHS trust; she has been the lead for Haemoglobinopathy service since 2016 and been an Educational Supervisor for haematology trainees in the region since 2008.

Dr. Mehta believes in keeping patient's choice and quality of life considerations at the centre of treatment decisions. Her keen research interest means that patients have the benefit of up to date evidence in managing their condition.


Diseases, Medical Tests and Treatments
  • Venesections
  • Chemotherapy and supportive care
  • Blood transfusions
  • Blood clot/thrombosis test
  • Blood type or blood group test
  • Haematology coagulation
  • Myeloproliferative neoplasms
  • Myelodysplastic syndrome
  • Haematological oncology 
Read more
4 Trumpington Road, Cambridge, United Kingdom, CB2 8AF - 309.45 miles
Nuffield Health Cambridge Hospital - 309.45 miles
4 Trumpington Road, Cambridge, United Kingdom, CB2 8AF
31 years of experience
Acute Myeloid Leukaemia (AML), Amyloidosis, Anaemia, Blood Cancer + 6 more

Dr. Charles Crawley undertook his initial medical training at St George’s University, London. He undertook postgraduate training at St Bartholomew’s Hospital and the Hammersmith Hospital follow by a Transplantation Fellowship at Hutchinson Cancer Centre, Seattle, USA.

After this, Dr. Crawley moved to Cambridge to take up his current post in 2003; and remains in Cambridge where he undertakes both NHS and private practice. His specialist interests include haematopoietic stem cell transplantation, myeloma and acute leukaemia and he is the principal investigator in a number of trials of novel stem cell therapies and therapies for myeloma.

In addition to his practice and his research work, Dr. Crawley is a member of the NCRI myeloma subcommittee and has been on the board of the British Society of Blood and Bone Marrow Transplantation for the last five years. He is currently Chair of the Drugs and Therapeutics Committee.


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Hemato-oncology
  • Stem Cell Transplatation
  • Myeloma
  • Haematological oncology
  • Leukaemia
  • Stem cell transplantation
Read more
Old Rd, Headington, Oxford, United Kingdom, OX3 7LE - 310.19 miles
Churchill Hospital - 310.19 miles
Old Rd, Headington, Oxford, United Kingdom, OX3 7LE
18 years of experience
Amyloidosis, Anaemia, Blood Cancer, Bone Marrow Tests & Biopsies + 5 more

Dr. Ramasamy undertook his general medical training in Nottingham, followed by early haematology training at Glasgow Royal Infirmary. Subsequently moved to London in 2002 and undertook a comprehensive haematology training programme encompassing all subspecialties of haematology, including bone marrow transplantation at Kings College Hospital. After this, he completed three years as a clinical research fellow at Kings College London in cancer studies; pursuing his interest in cancer research. He now practices across both Oxford University Hospital NHS trust and Royal Berkshire in Haematology.

Dr. Ramasamy is the myeloma lead for Thames Valley Cancer network. He is a Chief Investigator of UK multicentre trials and has published more than 75 peer-reviewed articles and written chapters in haemato-oncology textbooks; continuing his passion for research and ensuring he is abreast of the newest information and cutting edge technologies to offer his patients the best possible diagnosis and treatment.


Diseases, Medical Tests and Treatments
  • Blood transfusion
  • Coagulation
  • Haematological oncology
  • Chemotherapy
  • Myeloma
  • Bone marrow transplantation
  • Haematological oncology; general haematology
  • Thrombosis
  • Blood disorders
  • Blood cancer
  • Plasma cell dyscrasias
Read more
Old Rd, Headington, Oxford, United Kingdom, OX3 7LE - 310.19 miles
Churchill Hospital - 310.19 miles
Old Rd, Headington, Oxford, United Kingdom, OX3 7LE
Acute Myeloid Leukaemia (AML), Blood Cancer, Bone Marrow Tests & Biopsies, Bone Marrow Transplant + 7 more

Dr Toby Eyre is a consultant haematologist at Oxford University Hospitals NHS Foundation Trust, specialising in the management of lymphoid malignancies. He is considered a national expert in the management of patients with lymphoma and patients with chronic lymphocytic leukaemia.

Dr. Eyre is active in the field of research and has completed an MD Doctorate Thesis in early phase trials and biomarker studies in aggressive lymphoid disease in 2017; he continues to have an ongoing interest in clinical trials. He completed his haematology training in the Oxford deanery between 2010 and 2017.

Toby is an investigator on a number of national UK lymphoma and chronic lymphocytic leukaemia trials and has published nearly 70 peer-review articles on areas of lymphoma and CLL and has presented regularly at national and international conferences. He is also a core member of the low grade lymphoma and elderly high grade lymphoma NCRI clinical studies group and a member of the BSCH guideline writing group for follicular lymphoma and post-transplantation lymphoproliferative disorders.

In addition to his practice and research, Dr. Eyre also has a strong interest in teaching and training and has completed a post-graduate Diploma in Medical Education.


Diseases, Medical Tests and Treatments

  • Immunotherapy
  • Chemotherapy
  • Lymphoma
  • CLL
  • Chronic Lymphocytic Leukaemia
  • Haemato-oncology
  • lymphoid malignancies
  • Hodgkins Lymphoma
  • Non-Hodgkins Lymphoma
  • Clinical trials
Read more
Old Rd, Headington, Oxford, United Kingdom, OX3 7LE - 310.19 miles
Churchill Hospital - 310.19 miles
Old Rd, Headington, Oxford, United Kingdom, OX3 7LE
26 years of experience

Anna Schuh is a Professor of the University of Oxford and an honorary consultant in haematology at Oxford University Hospitals. Her main clinical and research interests are with lymphoid diseases (in particular chronic lymphocytic leukaemia) and molecular diagnostics.

Dr. Schuh is active in the field of reseach. She has been a principle investigator for over 50 clinical trials investigating new treatments for patients with leukaemias and lymphomas. As the head of the Oxford Molecular Diagnostic Centre, she leads on a research programme on improving response prediction for cancers, leukaemias and lymphomas using whole genome technologies and receives grants from NIHR, Wellcome Trust and Innovate UK.

As a result of her clinical practice and research achievements, she was asked to chair the UK's National Cancer Research Institute CLL working party.

Diseases, Medical Tests and Treatments

  • Chemotherapy
  • Leukaemia
  • Molecular diagnostics
  • Haematological oncology
Read more